Treatment of Dry Eye 

IPL System

  •  IPL System LACRYSTIM 
  • A safe and effective treatment fo all skin types
  • Immediate and lasting results
  •  Comfort and ease to use
LacryStim

Overview

IPL SYSTEM: TREATS THE CAUSES OF DRY EVE OPTIMISES LONG-TERMS RESULTS

Treatment of Meibomian gland dysfunction (MGD) 
 
A safe and effective treatment for all skin types.
 
Simple and fast treatment  (<5 min)
 
  • MECHANISMS OF ACTION
 
Several studies detail the mechanisms of action of IPL systems: :
 
Neurostimulation of the parasympathetic nerve pathways[1,2]
Tear production is stimulated by the nervous system, via the parasympathetic nerve [3], which is linked to bath the lac rimai gland [3,4] and the meibomian glands [3,5].
 
Faster meibomian gland metabolism [1,2,3,4,5]
 
lncreased meibum expression due to heat [6].
 
Small vessel coagulation: acts against inflammation of the skin (rosacea) and eyelids (blepharitis) [7,8,9].
 
Reduces Demodex mites.
  • CLINICAL RESULTS

The expected results of IPL treatment may include [6]:

 
lmproved tear film quality. 
 
 
Patient-reported improvement in the following symptoms: dryness, sensation of foreign body in the eye, itching, burning, eye fatigue, blurred vision, sensitivity to light, watery eyes, impaired secretion, pain.
 
 
Additional effects of IPL treatment may be observed:
 
- Pain relief
- Anti-inflammatory action (blepharitis, conjunctivitis, rosacea)
- Reduction in inflammatory markers (cytokines) in the tears [10]
- Antimicrobial action (bacteria and Demodex mites).
 
  • LIGHT SPECTRUM 
An IPL device is a generator of polychromatic intense pulsed light.
The LacryStim light spectrum extends from 610 nm to 1200 nm.
LacryStim uses a 610 nm filter that blacks UVA, UVB and UVC rays.
Thanks to this 610 nm filter:
- The melanin in the skin absorbs less light [11]
- No phototyping is required
- All types of skin can be treated, including black skin (Fitzpatrick scale phototype VI).
  • SETTINGS AND PULSES SEQUENCE
 
The total energy is between 8 and 12 J/cm2 and is delivered in a sequence of pulses.
 
The time between each pulse respects the thermal relaxation time (TRT) of the skin, thus limiting:
- The increase in tissue tempe rature
- Thermal damage to the skin
- lnflammatory reactions
- The phototyping required.
  • A SAFE AND EFFECTIVE TREATMENT FOR ALL SKIN TYPES

 

  • COMFORT AND EASE OF USE

A single handpiece, no additional kit required.

Integrated water cooling.
 
Does not burn the skin.
 
Applies a thin layer of gel during treatment.
 
Long-lasting flash lamp.
 
Delivers the same energy level from first to last shot.

 

  • SIMPLE AND FAST TREATMENT

SESSION 1 : Day 0

SESSION 2 : Day 7 to  15

SESSION 3 : Day 15 to 30

SESSION 4 : Day > 30 Optional

 

Short session A few minutes

Thin layer of gel 

Series of 4 shots Between the cheekbone and temples

  • BIBLIOGRAPHY

 

1. Parasympathe6c Innervation of the Meibomian Glands in Rats - Mark, S. leDoux, Qihong Zhou, R. Bryan Murphy, Mehssa, l. Greene y Patrick Ryan - lnvestigative Ophthalmology & V,sual Science, octubre de 2001, Vol. 42, No. 11 
 
2. Neurotransmitter Influence on Human Meibomian Gland Epith•lial Cells - Wendy R Kam y David A Sullivan - lnvestigative Ophthalmology & Visual Science, noviembre de 2011, vol. 52, No. 12 
 
3. TFOS DEWS Il - Rapport Physiopathologie, Anthony J. Bron, FRCOph, FMedSci, Cintia S. de Paiva, MD, PhDI, Sunil K Chauhsn, DVM, PhDl, Stefano Bonini, MO, Eric E. Gabison, MD, Ssndoep Jain, MD, Erich Knop, MD, PhD, Maria Markoul/i, PhD, MOptom, Yoko Ogawa, MD, Victor Pérez, MO, Yuichi Uchino, MD, PhD, Norihiko Yokoi, MD, PhD, Driss Zoukhri, PhD, David A. Sullivan, PhD, Th• Ocular Suif ace, 2017, pp. 441-515 
 
4. Vasoactive Intestinal Polypeptide and the Innervation of the HtJman Lac rimai Gland, Patrtck A. Sibony, MD; Benjamin Walcott. PhD; Cissy McKeon, Frederick A. Jakobiec, MD, Arch Ophthalmol. 1988;106/81. pp. 1085-1088 
 
5. The neurobiology of the meibomia11 gla11ds, Cox SM, Nichols JJ, Ocular Surface, ,ulio de 2014 
 
6. Arica R. et al. Mulr,center Study of Intense Pulsed Ught Therapy for Patients W1th Refractory Meibomian Gland Dysfunction • Reiko Arita, MD, PhD, Takano,i Mizoguchi, MD, Shima Fukuoka, MD, and Naoyuki Morishigs, MD, PhO • Comea, volumsn 37, mimera 12, diciBmbre de 2018 
 
7. Rosaces: Molecular Mechsnisms and Msnsgement of a Chronic Cutaneous lnflammstory Condition, Yu Ri Woo, Ji Hong L,m. Dae Ho Cho and HyunJeong Park, International Journal of Molecular Sciences. soptiembre de 2016 
 
8. Rosacea: Epidemiology, pathogem1sis, and treatment, Barbara M. Rainer; Sewon K(1ng, and Anna L. Chien, DERMATO-ENDOCRINOLOGY 2018, VOL. 9, NO. 1, e/361574 (IOpàginas/ 
 
9. Update on the manageme11r of rosacea, Allison P Weinkle, Vladyslava Doktor, Jason Emer, Clinical, Cosmetic and Jnv11stigatlonsl Dermstology, abri/ de 2015 
 
10. Analysis of Cytokino Lov9/s in T9ars and Clinica/ Corrolations Alter Jnumse Pulsed Ught Treating Meibomian Gland Dysfunction - RUIXING LIU, BEI RONG, PING TU, YUN TANG, WENJING SONG, ROLANDO TOYOS, MELISSA TOYOS Y XIAOMING YAN - Am J Ophthalmol. 2017 en AJO.com. 
 
11. Theory of lasers and lamps - S. Mordon, r Michaud - Annales do dermatologie (2009) 136, supfsmsnro 6, S3066s310- www.scisncsdirsct.com 

Clinical

Videos

Published on 29 mai 2019 / LACRYSTIM - Treatment of Dry Eye

Dry eye is a particularly common disease that affects the health and well-being of millions of people worldwide. Meibomian gland dysfunction (MGD) is the leadin

Specifications

Lacrystim, systeme IPL

LacryStim
   
Technology : IPL (Intense Pulsed Light) Technology
Wavelength :  610 - 1200 nm
Fluence : 1 J - 15 J/cm²
Size : 580 (H) x 275 (L) x 280 (P) mm 
Weight : 25 kg
Filter : 610 nm filter, anti UVA, UVB and UVC filter
Cooling   :  Water cooling system
Flashlamp : Xenon flashlamp
Technical spécifications : 220 VAC

Specifications are subject to change without notice.
©2019. Quantel Medical, LacryStim™ is a registered trademark of Quantel Medical. All rights reserved.

General conditions of use

LacryStim IPL is a class llb medical device designed by CSB for QUANTEL MEDICAL and compliance assessed by IMQ CE 0051 . 

Also available

?
Brochure
Ask a question